Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 201–300 of 1,010
Mennechet, F. J. D., & Uzé, G. (2006) · Blood · doi:10.1182/blood-2005-10-4129 · Cited by 220
Chen, X., Oppenheim, J. J., Winkler‐Pickett, R. T., Ortaldo, J. R., & Howard, O. M. Z. (2006) · European Journal of Immunology · doi:10.1002/eji.200635873 · Cited by 219
Zhou, X., Kong, N., Wang, J., Fan, H., Zou, H., Horwitz, D., Brand, D., Liu, Z., & Zheng, S. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000598 · Cited by 219
“N aturally occurring CD4Foxp3 regulatory T cells (nTregs) play crucial roles in controlling autoimmune disease by maintaining immunological homeostasis and self-tolerance (1).”
BackgroundGrauer, O. M., Nierkens, S., Bennink, E., Toonen, L. W. J., Boon, L., Wesseling, P., Sutmuller, R. P. M., & Adema, G. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22607 · Cited by 212
“CD41FoxP31 Treg are crucially involved in controlling the magnitude and type of immune responses against self- and nonself antigens.(29) Several studies indicate that Treg play a significant role in the suppression of antitumor immunity, but still little is known regarding their presence and function within tumors.”
BackgroundHanabuchi, S., Ito, T., Park, W.-R., Watanabe, N., Shaw, J. L., Roman, E., Arima, K., Wang, Y.-H., Voo, K. S., Cao, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0804106 · Cited by 204
“The TR generated by TSLP-pDCs possess a typical feature of naturally occurring TR as previously reported in mice and humans (3, 34).”
BackgroundExtracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2–P2X7 pathway
Hubert, S., Rissiek, B., Klages, K., Huehn, J., Sparwasser, T., Haag, F., Koch-Nolte, F., Boyer, O., Seman, M., & Adriouch, S. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091154 · Cited by 207
“T reg cells have been shown to down-regulate many types of immune responses, including potentially harmful effector immune reactions (Sakaguchi, 2005).”
Defects in mucosal immunity leading to Crohn's disease
Cobrin, G. M., & Abreu, M. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00293.x · Cited by 208
Tregs control the development of symptomatic West Nile virus infection in humans and mice
Lanteri, M. C., O’Brien, K. M., Purtha, W. E., Cameron, M. J., Lund, J. M., Owen, R. E., Heitman, J. W., Custer, B., Hirschkorn, D. F., Tobler, L. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39387 · Cited by 212
CD4+CD25+ Tregs and NKT cells: regulators regulating regulators
Cava, A. L., Kaer, L. V., & Fu-Dong-Shi (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.003 · Cited by 208
Immunological Responses to Exogenous Insulin
Fineberg, S. E., Kawabata, T. T., Finco-Kent, D., Fountaine, R. J., Finch, G. L., & Krasner, A. S. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0002 · Cited by 209
DiPaolo, R. J., Brinster, C., Davidson, T. S., Andersson, J., Glass, D., & Shevach, E. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4685 · Cited by 205
“Although nTregs have been shown to prevent IL-2 production and proliferation of responding T cells in vitro (4), the mechanism(s) used by nTregs in vivo is more complex and controversial, with possibilities ranging from the suppression of initial activation and proliferation, differentiation, migration, and effector f…”
BackgroundThymic development of gut-microbiota-specific T cells
Zegarra-Ruiz, D. F., Kim, D. V., Norwood, K., Kim, M., Wu, W.-J. H., Saldana-Morales, F. B., Hill, A. A., Majumdar, S., Orozco, S., Bell, R., et al. (2021) · Nature · doi:10.1038/s41586-021-03531-1 · Cited by 208
Feger, U., Tolosa, E., Huang, Y.-H., Waschbisch, A., Biedermann, T., Melms, A., & Wiendl, H. (2007) · Blood · doi:10.1182/blood-2006-11-057125 · Cited by 198
Farinha, P., Al-Tourah, A., Gill, K., Klasa, R., Connors, J. M., & Gascoyne, R. D. (2010) · Blood · doi:10.1182/blood-2009-07-235598 · Cited by 200
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
Beers, D. R., Zhao, W., Liao, B., Kano, O., Wang, J., Huang, A., Appel, S. H., & Henkel, J. S. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.12.008 · Cited by 198
IPEX as a Result of Mutations in FOXP3
van der Vliet, H. J. J., & Nieuwenhuis, E. E. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/89017 · Cited by 199
Toll-like receptors on regulatory T cells: expanding immune regulation
Sutmuller, R. P. M., Morgan, M. E., Netea, M. G., Grauer, O., & Adema, G. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.005 · Cited by 205
Regulating immunity to malaria
RILEY, E. M., WAHL, S., PERKINS, D. J., & SCHOFIELD, L. (2006) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00775.x · Cited by 202
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
Saruta, M., Yu, Q. T., Fleshner, P. R., Mantel, P.-Y., Schmidt-Weber, C. B., Banham, A. H., & Papadakis, K. A. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.003 · Cited by 204
Maillard, M. H., Cotta-de-Almeida, V., Takeshima, F., Nguyen, D. D., Michetti, P., Nagler, C., Bhan, A. K., & Snapper, S. B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061338 · Cited by 200
“Because nTreg cells are known to control autoimmunity in several disease states (17), we hypothesized that the colitis in WKO mice may be associated with aberrant diff erentiation, development, or function of nTreg cells.”
BackgroundGalectin-3 in autoimmunity and autoimmune diseases
de Oliveira, F. L., Gatto, M., Bassi, N., Luisetto, R., Ghirardello, A., Punzi, L., & Doria, A. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215593826 · Cited by 203
Ding, Y., Shen, S., Lino, A. C., Curotto de Lafaille, M. A., & Lafaille, J. J. (2008) · Nature Medicine · doi:10.1038/nm1707 · Cited by 200
An, C., Shi, Y., Li, P., Hu, X., Gan, Y., Stetler, R. A., Leak, R. K., Gao, Y., Sun, B.-L., Zheng, P., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.12.002 · Cited by 202
de la Rosa, G., Yang, D., Tewary, P., Varadhachary, A., & Oppenheim, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6868 · Cited by 199
“Treg consist of a subset of CD4 T cells that express the transcriptional factor FoxP3 and play a critical role in down-regulating immune activation (30).”
BackgroundSfikakis, P. P., Souliotis, V. L., Fragiadaki, K. G., Moutsopoulos, H. M., Boletis, J. N., & Theofilopoulos, A. N. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.12.006 · Cited by 202
Regulatory T Cells in Human Autoimmune Thyroid Disease
Marazuela, M., García-López, M. A., Figueroa-Vega, N., de la Fuente, H., Alvarado-Sánchez, B., Monsiváis-Urenda, A., Sánchez-Madrid, F., & González-Amaro, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2337 · Cited by 201
“terized by a constitutive high expression of CD25 (7).”
BackgroundMontagnoli, C., Fallarino, F., Gaziano, R., Bozza, S., Bellocchio, S., Zelante, T., Kurup, W. P., Pitzurra, L., Puccetti, P., & Romani, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1712 · Cited by 203
“with cyclophosphamide, known to deplete natural Treg (27), confirmed that early Treg act by limiting the inflammatory response at the expenses of fungal growth.”
BackgroundDetection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
Maeda, Y., Nishikawa, H., Sugiyama, D., Ha, D., Hamaguchi, M., Saito, T., Nishioka, M., Wing, J. B., Adeegbe, D., Katayama, I., et al. (2014) · Science · doi:10.1126/science.aaa1292 · Cited by 200
Self-citationPrognostic impact of tumour‐infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
Schreck, S., Friebel, D., Buettner, M., Distel, L., Grabenbauer, G., Young, L. S., & Niedobitek, G. (2009) · Hematological Oncology · doi:10.1002/hon.878 · Cited by 188
Humrich, J. Y., Morbach, H., Undeutsch, R., Enghard, P., Rosenberger, S., Weigert, O., Kloke, L., Heimann, J., Gaber, T., Brandenburg, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903158107 · Cited by 194
“R CD4 + T cells (Treg) that express the transcription factor Foxp3 are crucial for the maintenance of immunological tolerance to self (1, 2).”
BackgroundCD226 opposes TIGIT to disrupt Tregs in melanoma
Fourcade, J., Sun, Z., Chauvin, J.-M., Ka, M., Davar, D., Pagliano, O., Wang, H., Saada, S., Menna, C., Amin, R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121157 · Cited by 199
Human regulatory T cells induce T-lymphocyte senescence
Ye, J., Huang, X., Hsueh, E. C., Zhang, Q., Ma, C., Zhang, Y., Varvares, M. A., Hoft, D. F., & Peng, G. (2012) · Blood · doi:10.1182/blood-2012-03-416040 · Cited by 198
Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis
Yu, Q. T., Saruta, M., Avanesyan, A., Fleshner, P. R., Banham, A. H., & Papadakis, K. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20053 · Cited by 192
TGF-β and Regulatory T Cell in Immunity and Autoimmunity
Wan, Y. Y., & Flavell, R. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9251-y · Cited by 186
“specifically in nTreg among the lymphocyte populations [35, 109, 110].”
Teng, M. W. L., Ngiow, S. F., von Scheidt, B., McLaughlin, N., Sparwasser, T., & Smyth, M. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1681 · Cited by 192
Bonelli, M., Savitskaya, A., Steiner, C.-W., Rath, E., Smolen, J. S., & Scheinecker, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1689 · Cited by 195
Kim, R., Emi, M., & Tanabe, K. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02430.x · Cited by 191
Regulatory T Cells and Human Disease
Cools, N., Ponsaerts, P., Van Tendeloo, V. F. I., & Berneman, Z. N. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/89195 · Cited by 190
Role of regulatory T cell in the pathogenesis of inflammatory bowel disease
Yamada, A., Arakaki, R., Saito, M., Tsunematsu, T., Kudo, Y., & Ishimaru, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2195 · Cited by 191
Yan, B., Ye, S., Chen, G., Kuang, M., Shen, N., & Chen, S. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23268 · Cited by 186
“Self tolerance is critical for the maintenance of immune homeostasis, and the prevention of autoimmunity is mediated in part by CD4 ,CD25 regulatory T cells, which constitute 5–10% of peripheral blood CD4 T cells in normal mice and humans (1,2).”
BackgroundNa, K.-S., Mok, J.-W., Kim, J. Y., Rho, C. R., & Joo, C.-K. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9417 · Cited by 181
Joosten, S. A., van Meijgaarden, K. E., Savage, N. D. L., de Boer, T., Triebel, F., van der Wal, A., de Heer, E., Klein, M. R., Geluk, A., & Ottenhoff, T. H. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702257104 · Cited by 185
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Cen, X., Liu, S., & Cheng, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00878 · Cited by 188
“…playing a significant role in the tumor immunosurveillance, the CD4+ CD25+ Foxp3+ regulatory Tregs induced by various mechanism, enable to counteract the antitumor CTL response, resulting in the poor immunogens and immunosurveillance escape of tumor cells (Sakaguchi, 2005; Vignali et al., 2008).”
BackgroundLitzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., & Palena, C. (2007) · Blood · doi:10.1182/blood-2007-06-094615 · Cited by 188
Regulatory T cells in obesity: the leptin connection
Matarese, G., Procaccini, C., De Rosa, V., Horvath, T. L., & La Cava, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.002 · Cited by 185
WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells
Marangoni, F., Trifari, S., Scaramuzza, S., Panaroni, C., Martino, S., Notarangelo, L. D., Baz, Z., Metin, A., Cattaneo, F., Villa, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061334 · Cited by 184
“nTreg cells are readily present in the thymus, blood, and secondary lymphoid organs of healthy individuals or mice and represent 5–10% of the total CD4+ T cells (2).”
BackgroundTaylor, J. J., Mohrs, M., & Pearce, E. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5839 · Cited by 189
Samy, E. T., Parker, L. A., Sharp, C. P., & Tung, K. S. K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041033 · Cited by 181
“There is now general acceptance that natural CD4 CD25 T cells that express the functional transcription factor, Foxp3 , are an important cellular component of the normal immune system (1).”
BackgroundFOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Kryczek, I., Liu, R., Wang, G., Wu, K., Shu, X., Szeliga, W., Vatan, L., Finlayson, E., Huang, E., Simeone, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3804 · Cited by 179
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study
Thonhoff, J. R., Beers, D. R., Zhao, W., Pleitez, M., Simpson, E. P., Berry, J. D., Cudkowicz, M. E., & Appel, S. H. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000465 · Cited by 182
Zohar, Y., Wildbaum, G., Novak, R., Salzman, A. L., Thelen, M., Alon, R., Barsheshet, Y., Karp, C. L., & Karin, N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71951 · Cited by 184
Foxp3+ T-Regulatory Cells in Sjögren's Syndrome
Christodoulou, M. I., Kapsogeorgou, E. K., Moutsopoulos, N. M., & Moutsopoulos, H. M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080246 · Cited by 177
Clark, R. A., & Kupper, T. S. (2007) · Blood · doi:10.1182/blood-2006-02-002873 · Cited by 179
Gaardbo, J. C., Hartling, H. J., Gerstoft, J., & Nielsen, S. D. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/670957 · Cited by 180
“Either way, it does not answer the question whether the increased IA is the result of more upstream deficits.”
BackgroundHoming to suppress: address codes for Treg migration
Huehn, J., & Hamann, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.10.001 · Cited by 181
Baxevanis, C. N., Perez, S. A., & Papamichail, M. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360902937809 · Cited by 175
“Tregs are a subset of CD4+ T cells that are known to inhibit both the activation and proliferation of cytotoxic and helper T cells, and they are likely to play a major role in the induction of functional immune tolerance to tumours often observed in cancer patients.(194) Other regulatory CD4+ T-cell subsets likely tar…”
BackgroundWagner, N., Brandhorst, G., Czepluch, F., Lankeit, M., Eberle, C., Herzberg, S., Faustin, V., Riggert, J., Oellerich, M., Hasenfuss, G., et al. (2013) · Obesity · doi:10.1002/oby.20087 · Cited by 177
“In this regard, adoptive transfer of induced Treg cells could ameliorate the adipose tissue inflammation and metabolic abnormalities in obese mice (6).”
BackgroundPhenotypical characterization of regulatory T cells in humans and rodents
Rodríguez-Perea, A. L., Arcia, E. D., Rueda, C. M., & Velilla, P. A. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12804 · Cited by 166
Meiron, M., Zohar, Y., Anunu, R., Wildbaum, G., & Karin, N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080730 · Cited by 168
You, S., Leforban, B., Garcia, C., Bach, J.-F., Bluestone, J. A., & Chatenoud, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701171104 · Cited by 180
Kassan, M., Galan, M., Partyka, M., Trebak, M., & Matrougui, K. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.233262 · Cited by 176
Austin, P. J., Kim, C. F., Perera, C. J., & Moalem-Taylor, G. (2012) · Pain · doi:10.1016/j.pain.2012.06.005 · Cited by 180
“nTregs, which, like conventional T cells, express TCRab, normally constitute only 5–10% of T cells [56].”
BackgroundShachar, I., & Karin, N. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0612293 · Cited by 174
“nisms, among them, suppressor cytokine production [1, 2],”
Cytokines in recurrent pregnancy loss
Saini, V., Arora, S., Yadav, A., & Bhattacharjee, J. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.01.002 · Cited by 175
Page, S. T., Plymate, S. R., Bremner, W. J., Matsumoto, A. M., Hess, D. L., Lin, D. W., Amory, J. K., Nelson, P. S., & Wu, J. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00484.2005 · Cited by 170
“Studies in both mice and humans have demonstrated the crucial role of CD4 CD25 FoxP3 regulatory T cells in the suppression of effector responses to self-antigen (autoimmunity) (2, 24, 38).”
BackgroundInfluentialSzurek, E., Cebula, A., Wojciech, L., Pietrzak, M., Rempala, G., Kisielow, P., & Ignatowicz, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141161 · Cited by 163
“Introduction Regulatory CD4Foxp3 T cells (Tregs) play an indispensable role in maintaining homeostasis of the immune system by preventing autoimmunity and by controlling the strength and duration of immune responses against a variety of self and non-self antigens [1, 2].”
BackgroundCrane, C. A., Ahn, B. J., Han, S. J., & Parsa, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos014 · Cited by 169
“healthy patients and directly counteract the proliferation and cytokine production by conventional T cells.(14) In patients with high-grade glioma, reports demonstrate that up to 60% of the tumor-infiltrating lymphocyte (TIL) population is composed of Treg.”
Prud'homme, G., Glinka, Y., Khan, A., & Draghia-Akli, R. (2006) · Current Gene Therapy · doi:10.2174/156652306776359504 · Cited by 175
Fritzsching, B., Oberle, N., Pauly, E., Geffers, R., Buer, J., Poschl, J., Krammer, P., Linderkamp, O., & Suri-Payer, E. (2006) · Blood · doi:10.1182/blood-2006-02-005660 · Cited by 172
Molecular mechanism of curcumin action in signaling pathways: Review of the latest research
Liczbiński, P., Michałowicz, J., & Bukowska, B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6663 · Cited by 168
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
Graßhoff, H., Comdühr, S., Monne, L. R., Müller, A., Lamprecht, P., Riemekasten, G., & Humrich, J. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648408 · Cited by 167
“Predominantly derived from a distinct CD4+ T cell subpopulation in the thymus, FoxP3+ Treg principally recognize auto-antigens and are required to control the activation, differentiation and expansion of autoreactive T cells and other potentially harmful immune cells in the peripheral lymphatic organs (15, 21, 22).”
BackgroundThe Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells
Gregori, S., Goudy, K. S., & Roncarolo, M. G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00030 · Cited by 161
“FOXP3+ Treg are identified by standard flow cytometry techniques based on their constitutively high expression of CD25 and the transcription factor FOXP3 (Sakaguchi, 2005).”
BackgroundFoxp3+ regulatory T cells in the control of experimental CNS autoimmune disease
O'Connor, R. A., & Anderton, S. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.016 · Cited by 173
Regulatory T cells in stem cell transplantation: strategies and first clinical experiences
Edinger, M., & Hoffmann, P. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.06.006 · Cited by 167
O’Connor, R. A., Malpass, K. H., & Anderton, S. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.958 · Cited by 168
CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
Mousavi, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2019.11.007 · Cited by 165
Wang, R., Wan, Q., Kozhaya, L., Fujii, H., & Unutmaz, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002705 · Cited by 162
“Human and murine Tregs share similar characteristics, such as hypo-responsiveness to T cell receptor (TCR) activation and mediation of their suppressive activity through cell-contact-dependent mechanisms [1].”
BackgroundInfluentialNaive B cells generate regulatory T cells in the presence of a mature immunologic synapse
Reichardt, P., Dornbach, B., Rong, S., Beissert, S., Gueler, F., Loser, K., & Gunzer, M. (2007) · Blood · doi:10.1182/blood-2006-10-053793 · Cited by 168
Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis
Hui, W., Yu, D., Cao, Z., & Zhao, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.018 · Cited by 160
Powell, D. J., Felipe-Silva, A., Merino, M. J., Ahmadzadeh, M., Allen, T., Levy, C., White, D. E., Mavroukakis, S., Kreitman, R. J., Rosenberg, S. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4919 · Cited by 166
“Although CD4 T cells can provide help to enhance CD8mediated responses through the production of soluble factors such as IL-2 and the ability to activate APCs (13), a subset of these cells, CD25 CD4 T regulatory (Treg)(3) cells, possesses the ability to suppress T cell responses and regulate tolerance to self proteins…”
BackgroundCirculating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection
Peng, G., Li, S., Wu, W., Sun, Z., Chen, Y., & Chen, Z. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02691.x · Cited by 170
FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability
León, B., Bradley, J. E., Lund, F. E., Randall, T. D., & Ballesteros-Tato, A. (2014) · Nature Communications · doi:10.1038/ncomms4495 · Cited by 160
Thymic microenvironments for T cell differentiation and selection
Ladi, E., Yin, X., Chtanova, T., & Robey, E. A. (2006) · Nature Immunology · doi:10.1038/ni1323 · Cited by 165
“T reg cells help to maintain self-tolerance by actively suppressing immune response”
BackgroundSong, X.-T., Kabler, K. E., Shen, L., Rollins, L., Huang, X. F., & Chen, S.-Y. (2008) · Nature Medicine · doi:10.1038/nm1721 · Cited by 163
“CD4 + CD25 + Foxp3 + T reg cells have an essential role in suppressing autoimmune responses, including those against TA”
BackgroundTGF-β and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3
Samanta, A., Li, B., Song, X., Bembas, K., Zhang, G., Katsumata, M., Saouaf, S. J., Wang, Q., Hancock, W. W., Shen, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806726105 · Cited by 161
“FOXP3 exerts a defining role in regulatory T (Treg) cell function and FOXP3 expression levels correlate with the suppressive capability of Treg cells (1, 2, 5, 6).”
BackgroundPhenotypic and Functional Properties of Helios+ Regulatory T Cells
Zabransky, D. J., Nirschl, C. J., Durham, N. M., Park, B. V., Ceccato, C. M., Bruno, T. C., Tam, A. J., Getnet, D., & Drake, C. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034547 · Cited by 160
CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function
Golovina, T. N., Mikheeva, T., Suhoski, M. M., Aqui, N. A., Tai, V. C., Shan, X., Liu, R., Balcarcel, R. R., Fisher, N., Levine, B. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2855 · Cited by 164
Pathological and Clinical Correlates of FOXP3+ Cells in Renal Allografts during Acute Rejection
Veronese, F., Rotman, S., Smith, R. N., Pelle, T. D., Farrell, M. L., Kawai, T., Benedict Cosimi, A., & Colvin, R. B. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01704.x · Cited by 164
Menning, A., Höpken, U. E., Siegmund, K., Lipp, M., Hamann, A., & Huehn, J. (2007) · European Journal of Immunology · doi:10.1002/eji.200737201 · Cited by 160
Bear, A. S., Kennedy, L. C., Young, J. K., Perna, S. K., Mattos Almeida, J. P., Lin, A. Y., Eckels, P. C., Drezek, R. A., & Foster, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069073 · Cited by 163
“Although these strategies have improved the systemic antitumor effects of thermal ablation, they rely solely on the endogenous generation and expansion of tumor-specific T cells within the tumor-bearing host, a setting with an abundance of suppressive influences generated by the host immune system [45] and tumor micro…”
BackgroundHuman Milk and Allergic Diseases: An Unsolved Puzzle
Munblit, D., Peroni, D. G., Boix-Amorós, A., Hsu, P. S., Land, B. V., Gay, M. C. L., Kolotilina, A., Skevaki, C. L., Boyle, R. J., Collado, M. C., et al. (2017) · Nutrients · doi:10.3390/nu9080894 · Cited by 185
“These processes are important for the production of functional T cells, which are able to recognize and respond to foreign/microbial antigens presented by the MHC in the periphery, but also Foxp3+ regulatory T (Treg) cells, which mediate immune tolerance to self and a variety of self and foreign antigens [92].”
Social interaction in synthetic and natural microbial communities
Xavier, J. B. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.16 · Cited by 158
“Such autoimmune responses are prevented, in part, by the presence of cell type, the regulatory T cells (Tregs; Sakaguchi, 2005; Pandiyan et al, 2007).”
Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis
Kelchtermans, H., Geboes, L., Mitera, T., Huskens, D., Leclercq, G., & Matthys, P. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.086066 · Cited by 160
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
Lee, C.-H., Yelensky, R., Jooss, K., & Chan, T. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.005 · Cited by 162
Erfani, N., Mehrabadi, S. M., Ghayumi, S. M. A., Haghshenas, M. R., Mojtahedi, Z., Ghaderi, A. A., & Amani, D. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.04.011 · Cited by 169
“Treg cells diminish he activation and the function of lymphocytes via cell-cell conact and secretion of soluble mediators [3].”
BackgroundLüth, S., Huber, S., Schramm, C., Buch, T., Zander, S., Stadelmann, C., Brück, W., Wraith, D. C., Herkel, J., & Lohse, A. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32132 · Cited by 161
“In vivo, the majority of Tregs seems to be generated in the thymus (8); however, these cells may”
BackgroundSwain, S. L., Agrewala, J. N., Brown, D. M., Jelley‐Gibbs, D. M., Golech, S., Huston, G., Jones, S. C., Kamperschroer, C., Lee, W., McKinstry, K. K., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00388.x · Cited by 163
“These cells have been extensively reviewed in recent publications (12, 13) and will not be included here.”
BackgroundWehrens, E. J., Mijnheer, G., Duurland, C. L., Klein, M., Meerding, J., van Loosdregt, J., de Jager, W., Sawitzki, B., Coffer, P. J., Vastert, B., et al. (2011) · Blood · doi:10.1182/blood-2010-12-328187 · Cited by 164
STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer
Oweida, A. J., Darragh, L., Phan, A., Binder, D., Bhatia, S., Mueller, A., Court, B. V., Milner, D., Raben, D., Woessner, R., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz036 · Cited by 156
“Tregs play a major role in dampening spontaneous tumor-associated antigen (TAA)-specific immune responses (13,14).”
BackgroundInduction of organ‐selective CD4+ regulatory T cell homing
Siewert, C., Menning, A., Dudda, J., Siegmund, K., Lauer, U., Floess, S., Campbell, D. J., Hamann, A., & Huehn, J. (2007) · European Journal of Immunology · doi:10.1002/eji.200636575 · Cited by 159
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.